Zentek Announces Grant of Stock Options
Zentek Announces Grant of Stock Options
Guelph, Ontario
安大略省圭尔夫
Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN) announces the granting of options to acquire an aggregate of 1,935,000 common shares to certain directors, officers and employees of the Company, exercisable at a price of $1.52 per common share for a period of five years from the date of the grant. For directors and officers, the options will vest one third on the date of grant, one third on the first anniversary of the grant, and one third on the second anniversary of the grant. For employees, the options will vest one quarter on the date of grant, and one quarter on each anniversary thereafter.
Zentek Ltd.(“Zentek”或“公司”)(纳斯达克:ZTEK;tsx-V:ZEN)宣布授予期权,以获取共1,935,000股普通股,授予公司某些董事,高管和雇员可行权价为每股1.52美元的期权,期限为授予之日起五年。对于董事和高管,期权将在授予之日的三分之一,授予一周年的三分之一和授予二周年的三分之一时行使。对于员工,以授予之日的四分之一和此后每个周年四分之一股权份额授予期权。
About Zentek Ltd.
关于Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek是一家ISO13485:2016认证的知识产权技术公司,专注于研究、开发和商业化旨在使公司商业合作伙伴通过使其产品更好、更安全和更绿色而获得竞争优势的新产品。
Zentek's patented technology platform ZenGUARD, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD production facility is located in Guelph, Ontario.
Zentek的专利技术平台ZenGUARD显示有99%的抗微生物活性,并显著增加外科口罩的病毒过滤效率,并旨在为暖通空气处理(HVAC)系统做同样的事情。Zentek的ZenGUARD生产设施位于安大略省圭尔夫市。
For further information on Zentek:
有关Zentek的更多信息:
Ryan Shacklock
Ryan Shacklock
Senior VP, Strategy & Business Development
高级副总裁,策略和业务发展
Email: rshacklock@zentek.com
电子邮件: rshacklock@zentek.com
Phone: 306-270-9610
电话:306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
要了解有关Zentek的更多信息,请访问我们的网站www.Zentek.com。您可以在Zentek的SEDAR+档案中获取此新闻发布和所有材料文件的副本,网址为http://www.sedarplus.ca/.
Forward-Looking Statements
前瞻性声明
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
此新闻发布包含前瞻性声明。由于前瞻性声明涉及未来事件和条件,因此它们本质上涉及固有风险和不确定性。尽管Zentek相信在准备本新闻发布中的前瞻性信息时所使用的假设和因素是合理的,但不应对此类信息产生过度依赖,该信息仅适用于本新闻发布的发布日期,并且不能保证此类事件将在披露的时间范围内或根本不会发生。除法律要求外,Zentek不承担任何更新或修订任何前瞻性信息的意图或义务。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
TSX Venture Exchange及其监管服务提供商(如TSX Venture Exchange政策中定义的那样)均不对本发布内容的充分性或准确性承担责任。